Synthetic protein science platform for artificial molecule design
Location: United States, Washington, Seattle
Total raised: $50M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.08.2022 | Series A | $50M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 29.08.2022 | Vilya Launches With $50M in Series A Financing | Vilya, Inc., a Seattle, WA-based biotechnology company creating a new class of medicines that precis... | finsmes.co... |
| 29.08.2022 | Sneaky synthetic molecules open the way for new types of dru... | An illustration shows how custom-made peptide molecules (shown in pink and purple) can slip through ... | geekwire.c... |